ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hospitalist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,265Medicare Part D Prescriptions Filled, Including Refills
$742K Total Retail Price of All Prescriptions
540 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 573 557
LEVOTHYROXINE SODIUM 503 443
OMEPRAZOLE 364 347
WARFARIN SODIUM 256 255
METFORMIN HCL 251 228
FENOFIBRATE 251 238
ZOLPIDEM TARTRATE 247 236
LISINOPRIL 182 176
ATORVASTATIN CALCIUM 163 158
AMLODIPINE BESYLATE 160 160
CRESTOR 159 142
SYNTHROID 146 140
ZETIA 144 142
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 140
AZITHROMYCIN 137 128
CARVEDILOL 133 126
TAMSULOSIN HCL 132 126
LOSARTAN POTASSIUM 132 132
TRAMADOL HCL 126 106
CELEBREX 123 119
POTASSIUM CHLORIDE 119 119
FUROSEMIDE 112 111
HYDROCODONE-ACETAMINOPHEN 111 90 S3
GABAPENTIN 106 96
PAROXETINE HCL 104 103
TRIAMTERENE-HCTZ 103 88
FLUOXETINE HCL 98 97
LOSARTAN-HYDROCHLOROTHIAZIDE 96 93
MELOXICAM 92 92
LOVAZA 88 88
ALENDRONATE SODIUM 88 88
VERAPAMIL ER 87 87
WELCHOL 84 84
HYDROCHLOROTHIAZIDE 82 82
JANUVIA 74 74
GLIMEPIRIDE 74 69
PRAVASTATIN SODIUM 71 64
LANTUS 70 67
EVISTA 69 69
TRAZODONE HCL 68 60
CLOPIDOGREL 68 61
NAMENDA 67 67
DONEPEZIL HCL 66 66
AMLODIPINE BESYLATE-BENAZEPRIL 66 66
AMITRIPTYLINE HCL 65 50 R
LOVASTATIN 62 62
PROPRANOLOL HCL 61 60
METOPROLOL TARTRATE 59 59
BUPROPION HCL SR 59 58
FLUTICASONE PROPIONATE 58 53
CIPROFLOXACIN HCL 58 55
CITALOPRAM HBR 55 53
SERTRALINE HCL 54 51
ENALAPRIL MALEATE 54 54
RAMIPRIL 51 40
DIOVAN HCT 51 37
METOPROLOL SUCCINATE 51 51
NIASPAN 50 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.